January 22, 2012
Paul E. Sax, M.D., is director of the HIV Program and Division of Infectious Diseases at Brigham and Women's Hospital in Boston.
An e-mail from a patient last week:
Just got refills. Epivir is now generic??? Refill is simply labeled Lamivudine Tablets by Aurobindo Pharma USA, Inc ... but made in India. Should I be concerned about that???
I told John (not his real name) not to be concerned -- he is merely substituting the generic for the branded version, not switching from a fixed-dose combination or from a different drug (that drug being emtricitabine, or FTC).
But generic lamivudine for HIV treatment is a watershed moment nonetheless, since it's really the first time there's a generic antiretroviral that we might actually consider prescribing. (Zidovudine and didanosine have been generic for years.)
It will be fascinating to see how this plays out, both here in the US and in other developed countries.
Paul Sax is Clinical Director of Infectious Diseases at Brigham and Women's Hospital. His blog HIV and ID Observations is part of Journal Watch, where he is Editor-in-Chief of Journal Watch AIDS Clinical Care.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.